Most Clicked StoriesMore >


Study: Stem cells improve outcomes for patients with systemic sclerosis

AABB SmartBrief | Nov 25, 2014

Patients with progressive systemic sclerosis benefit over the long term from autologous hematopoietic stem cell transplantation, according to a five-year study presented at an American College of Rheumatology conference. Transplant patients had better survival rates and greater symptom relief than matched controls who did not receive stem cells. MedPage Today (free registration) (11/21)


Aggregations of cancer cells may be most likely to spread disease

AABB SmartBrief | Nov 24, 2014

Single-unit cord blood transplants benefit children with leukemia in study

AABB SmartBrief | Nov 25, 2014

Ebola session from AABB Annual Meeting available online

AABB SmartBrief | Nov 26, 2014

Hydroxyurea safe, effective for youths with sickle cell anemia, study finds

AABB SmartBrief | Nov 24, 2014

Study shows how Ebola protein causes inflammation, leaky blood vessels

AABB SmartBrief | Nov 24, 2014

FDA approves experimental use of Cerus' plasma treatment system

AABB SmartBrief | Nov 26, 2014

Microfluidic chip reduces amount of blood needed for testing

AABB SmartBrief | Nov 25, 2014

NeoStem releases early results from trial of cell therapy for heart attacks

AABB SmartBrief | Nov 25, 2014

Clotting risk increases with antiphospholipid antibodies

AABB SmartBrief | Nov 24, 2014


Find AABB SmartBrief Issues by Date:



AABB News More >


Ebola session from AABB Annual Meeting available online

AABB SmartBrief | Nov 26, 2014

Reminder: Comments on Proposed 9th Edition of IRL Standards due tomorrow, Nov. 26

AABB SmartBrief | Nov 25, 2014

AABB requests nominations for 2015, 2016 Memorial Awards

AABB SmartBrief | Nov 24, 2014

Reminder: 18th edition of AABB Technical Manual available for purchase

AABB SmartBrief | Nov 21, 2014

Reminder: NBF accepting applications for 2015 Scientific Research Grants

AABB SmartBrief | Nov 20, 2014




Sign up for AABB SmartBrief



Designed specifically for the transfusion medicine and cellular therapy community, AABB SmartBrief is a FREE, daily e-mail newsletter. It provides a summary of the most important news in our field to members of AABB and beyond. To save time and stay smart, sign up today to receive AABB SmartBrief, free of charge. Learn more